Propionate, the most potent agonist of GPR41 and GPR43, reduces proliferation and promotes apoptosis in colon cancer [8] and leukemia [7], but it is unclear if propionate enhances the effect of chemotherapy on cancer cells. Here, FFAR2 is linked to cancer.